National Comprehensive Cancer Network



About NCCN

Prostate Cancer Early Detection Panel - Disclosures as of 7/29/2014

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Gerald Andriole, MD

None

None

None

None

10/4/2012

Robert R. Bahnson, MD

None

None

None

None

6/9/2014

Daniel A. Barocas, MD, MPH

National Cancer Institute;
Agency for Healthcare Research and Quality

Dendreon Corporation;
Dendreon Corporation;
General Electric;
Jannsen Pharmaceutica Products, LP;
Jannsen Pharmaceutica Products, LP

None

None

5/2/2014

Peter R. Carroll, MD, MPH

Genomic Health, Inc.;
Myriad Genetic Laboratories, Inc.;
National Cancer Institute;
Department of Defense

None

None

None

7/8/2014

William J. Catalona, MD

Beckman-Coulter, Incorporated;
deCODE genetics, Inc;
Ohmx

Beckman Coulter Inc;
Beckman-Coulter, Inc;
deCODE genetics;
Ohmx

Ohmx Inc

Ohmx, Inc

5/27/2014

Douglas Dahl, MD

None

None

None

None

11/28/2012

John W. Davis, MD

Jannsen Pharmaceutica Products, LP;
Myriad Genetic Laboratories, Inc.;
Genprobe

Springer U.S.

None

None

7/16/2014

Jonathan I. Epstein, MD

None

None

None

None

8/15/2013

Ruth B. Etzioni, PhD

None

None

None

None

5/24/2013

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2013

George P. Hemstreet, III, MD, PhD

None

None

None

None

5/11/2012

Maria Ho, PhD

None

None

None

None

7/10/2014

Mark H. Kawachi, MD

None

None

None

None

6/4/2014

Paul H. Lange, MD

None

Dendreon Corporation

None

None

4/25/2013

Kevin R. Loughlin, MD

None

None

None

None

8/13/2013

William Lowrance, MD, MPH

National Cancer Institute;
Argos Therapeutics

Myriad Genetic Laboratories, Inc.

None

None

5/4/2014

Paul Maroni, MD

None

None

None

None

6/10/2013

Joan S. McClure, MS

None

None

None

None

6/20/2014

James L. Mohler, MD

Roswell Park Cancer Institute

Genomic Health, Inc.

None

Androbiosys, Inc.

5/2/2014

Todd M. Morgan, MD

Myriad Genetic Laboratories, Inc.

Myriad Genetic Laboratories, Inc.;
MDxHealth

None

None

7/7/2014

Robert B. Nadler, MD

None

None

None

None

7/14/2014

J. Kellogg Parsons, MD, MHS

Myriad Genetic Laboratories, Inc.

None

None

None

8/19/2013

Michael Poch, MD

None

Ferring Pharmaceuticals

None

None

12/21/2013

Chuck Scales, MD

None

None

None

None

1/24/2014

Terrence M. Shaneyfelt, MD, MPH

None

None

None

None

5/2/2014

Dorothy Shead, MS

None

None

None

None

8/19/2013

Marc C. Smaldone, MD, MSHP

       

Pending

Andrew J. Vickers, PhD

None

GenomeDX

Arctic Partners;
OPKO

Arctic Partners

7/11/2014

Robert Wake, MD

None

None

None

None

5/2/2014